• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Pyrazinamide

Pyrazinamide

Product ID P9671
Cas No. 98-96-4
Purity ≥98%
Product Unit SizeCostQuantityStock
10 g $61.00 In stock
25 g $102.00 In stock
100 g $325.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Pyrazinamide is a nicotinamide analog prodrug that exhibits antibiotic activity, inhibiting bacterial fatty acid synthetase I. Pyrazinamide displays antibacterial efficacy against both active and dormant bacteria, disrupting cell membranes, acidifying cytoplasm, and inhibiting membrane transport.

Product Info

Cas No.

98-96-4

Purity

≥98%

Formula

C5H5N3O

Formula Wt.

123.11

IUPAC Name

pyrazine-2-carboxamide

Synonym

Pyrazinecarboxamide, Pyranzinoic acid amide

Melting Point

189-191°C

Solubility

Soluble in water (15mg/mL).

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

P9671 MSDS PDF

Info Sheet

P9671 Info Sheet PDF

References

Singh P, Mishra AK, Malonia SK, et al. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria. J Commun Dis. 2006 Mar;38(3):288-98. PMID: 17373362.

Zhang Y, Wade MM, Scorpio A, et al. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother. 2003 Nov;52(5):790-5. PMID: 14563891.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • M3577

    Mitiglinide Calcium

    ATP-sensitive K+ channel blocker, potential RyR...

    ≥98%
  • N5210

    Nociceptin

    Endogenous neuropeptide, involved in opioid sig...

    ≥98%
  • P3568

    Pirarubicin

    Anthracycline, DNA intercalator; topoisomerase ...

    ≥98%
  • M1579

    Methazolamide

    Carbonic anhydrase inhibitor.

    ≥98%
  • P0260

    Papain Inhibitor

    Peptide produced in tomato leaves; potential ca...

    ≥95%
  • D0253

    Danazol

    Ethisterone derivative, synthetic steroid, used...

    ≥99%
  • C1630

    Cefoperazone Sodium

    β-lactam cephalosporin; penicillin binding pro...

    ≥98%
  • G3554

    Ginsenoside Rb3

    Triterpene saponin found in species of Panax.

    ≥98%
  • B6816

    Brefeldin A

    Lactone found in fungi such as Eupenicillium; g...

    ≥97%
  • E4417

    Eledoisin Related Peptide

    Peptide, substance P analog; NK agonist.

    ≥95%
  • A7208

    Ascomycin

    FK506 analog; calcineurin inhibitor.

    ≥98%
  • D0808

    DCC-2036

    Abl inhibitor.

    ≥98%
  • T2930

    Thiabendazole

    Benzimidazole; microtubule polymerization inhib...

    ≥98%
  • W0269

    (±)-Warfarin

    Coumarin; VKORC1 inhibitor.

    ≥98%
  • P014442

    Palbociclib

    CDK4/6 inhibitor.

    ≥98%
  • S0045

    Salbutamol Sulfate

    β2-adrenergic agonist.

    ≥98%
  • N0205

    Nabumetone

    1-Naphthalenacetic acid derivative, NSAID; COX-...

    ≥98%
  • I527211

    Infigratinib Phosphate

    FGFR inhibitor.

    ≥98%
  • A1607

    AEBSF Hydrochloride

    Serine protease substrate/inhibitor.

    ≥98%
  • C324091

    Ciclesonide

    Corticosteroid

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only